In this study, we sought to determine whether LL37 could actively contribute to the development of atheroma and therefore provide a potential explanation for the association between inflammatory disorders that feature high levels of LL37 and cardiovascular diseases. This evidence concerns the gene CAMP and cardiovascular disorder.